Arrowhead Pharmaceuticals
Trade Arrowhead Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
ARWR Key Statistics
Stock Snapshot
As of today, Arrowhead Pharmaceuticals(ARWR) shares are valued at $55.93. The company's market cap stands at 7.83B, with a P/E ratio of 37.43.
As of 2026-03-18, Arrowhead Pharmaceuticals(ARWR) stock has fluctuated between $55.49 and $58.20. The current price stands at $55.93, placing the stock +0.8% above today's low and -3.9% off the high.
Arrowhead Pharmaceuticals(ARWR) shares are trading with a volume of 527.6K, against a daily average of 2.64M.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $76.76 and a 52-week low of $9.57.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $76.76 and a 52-week low of $9.57.
ARWR News
In February 2026, Arrowhead Pharmaceuticals received US FDA approval for its first drug, REDEMPLO (plozasiran), for familial chylomicronemia syndrome, with addi...
